This journal aims to provide a forum for publication of clinical and experimental pharmacology studies related to diabetes, obesity and metabolism, including evaluations of new glucose and weight-lowering drugs, new therapeutic developments in the management and prevention of diabetic complications, e.g. growth factors and biotechnology products for foot ulcers, and clinical trials involving established medicines, e.g. optimal treatment of hypertension, lipids or infection in the diabetic population.

The journal invites brief review articles relevant to practising clinicians, original articles under separate sections of clinical and basic science, and provides a forum to publish hypotheses and letters to the editor on drug and therapeutic issues related to any aspect of diabetes, obesity and metabolism.